MediT Prefilled Pen: Convenience and Value
The MediT tirzepatide pen is ORYN's premium format designed for researchers with established dosing protocols:
40 mg Total Content: Four times the tirzepatide of the standard pen, providing significantly more research material per unit.
Weekly Administration: Prefilled single-use pen designed for once-weekly injection. No dose calculation, no multi-step preparation -- uncap, inject, dispose.
Cost Efficiency: At EUR 6.23 per milligram, the MediT pen delivers nearly 3x better value than the standard pen's EUR 16.90 per milligram. For long-term research protocols, this cost difference is substantial.
Ideal For: Established protocols where the optimal dose is already known. Long-term studies where convenience reduces protocol burden. Budget-conscious research programs maximising tirzepatide per euro spent.
Specifications: 40 mg tirzepatide, prefilled pen, >99% purity, GMP manufactured in South Korea, COA included. EUR 249.
Standard Tirzepatide Pen: Flexibility and Control
The standard tirzepatide pen is ORYN's versatile format for researchers who need dosing precision:
Adjustable Dosing: The multi-dose pen allows researchers to administer any amount per injection, from micro-doses to the full daily allocation. This precision is essential for dose-finding studies.
Daily Administration: 30-day supply with daily dosing provides 30 data points per cycle -- valuable for researchers tracking dose-response relationships or titrating to optimal levels.
Lower Entry Cost: At EUR 169 vs EUR 249, the standard pen has a lower upfront cost -- though the per-milligram cost is higher.
Ideal For: Dose-finding and dose-escalation research. Protocols requiring daily administration timing. Researchers who need to adjust doses based on interim observations. First-time tirzepatide research where the optimal dose is unknown.
Specifications: 10 mg tirzepatide, multi-dose pen, 30-day supply, >99% purity, GMP manufactured in South Korea, COA included. EUR 169.
Choosing the Right Format
The decision between MediT and standard pen comes down to protocol requirements:
Choose MediT (EUR 249) if: - Your protocol calls for weekly fixed-dose administration - You have already established the optimal dose for your research - Cost per milligram is a priority for your budget - Convenience and protocol simplicity are valued - You need 40 mg of tirzepatide per cycle
Choose Standard Pen (EUR 169) if: - Your research requires daily dosing or dose titration - You are in a dose-finding phase and need flexibility - You prefer to adjust doses based on interim observations - Lower upfront cost is preferred over per-mg efficiency - 10 mg is sufficient for your protocol duration
Quality Assurance: Both formats contain identical pharmaceutical-grade tirzepatide at >99% purity from GMP-certified South Korean facilities. Both include a Certificate of Analysis. The only differences are format, total content, and dosing schedule.
